DN memory B cells have been shown to be significantly reduced in rheumatoid arthritis patients treated with TNF inhibitors and tocilizumab [49], as well as in lupus patients with nephritis undergoing immunosuppressive therapy [50]. Here, TNF is linked to systemic lupus erythematosus.